BioStock interview with our CEO
Date: 2024-05-29
Kristina Torfgård, our CEO, comments on Alzinova’s lead candidate, ALZ-101, now in a higher dose.
Link to the full interview below.
Kristina Torfgård, our CEO, comments on Alzinova’s lead candidate, ALZ-101, now in a higher dose.
Link to the full interview below.